The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion

Published:2017-09-10 Issue:14 Volume:31 Page:2007-2016
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Donnell Deborah,Ramos Eric,Celum Connie,Baeten Jared,Dragavon Joan,Tappero Jordan,Lingappa Jairam R.,Ronald Allan,Fife Kenneth,Coombs Robert W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference35 articles.

1. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial;Choopanya;Lancet,2013

2. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med,2010

3. Preexposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial;McCormack;Lancet,2016

4. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection;Molina;N Engl J Med,2015

5. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana;Thigpen;N Engl J Med,2012

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Pre-Exposure Prophylaxis;Infectious Disease Clinics of North America;2024-09

2. Reassuring long-term safety, resistance, and efficacy data for two daily formulations of PrEP;The Lancet HIV;2024-08

3. HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial;The Lancet HIV;2024-08

4. Suppressed HIV antibody responses following exposure to antiretrovirals – evidence from PrEP randomized trials and early antiretroviral treatment initiation studies;International Journal of Infectious Diseases;2024-08

5. Modelling the impact of initiation delay, duration and prior PrEP usage on the prophylactic efficacy of FTC/TDF-containing post-exposure prophylaxis;2024-07-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3